VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Yukin Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 25 out of 100

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Yukin Therapeutics develops small molecules that inhibit the non-canonical NF-κB2 pathway. These new compounds have the potential to inhibit cancer cell proliferation and to massively modulate the tumour micro-environment.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy